对《γ-突触核蛋白是口腔癌恶性肿瘤中一种新型的尼古丁反应蛋白》的更正
Correction to: Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy.
作者信息
Hsu Chia-Chen, Su Yu-Fu, Tsai Kuo-Yang, Kuo Feng-Chih, Chiang Chi-Fu, Chien Chu-Yen, Chen Ying-Chen, Lee Chien-Hsing, Wu Yu-Chiao, Wang Kun, Liu Shyun-Yeu, Shieh Yi-Shing
机构信息
Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, 114 Taiwan.
Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114 Taiwan.
出版信息
Cancer Cell Int. 2020 Aug 26;20:410. doi: 10.1186/s12935-020-01478-3. eCollection 2020.
Abstract
[This corrects the article DOI: 10.1186/s12935-020-01401-w.].
摘要
[本文更正了文章的数字对象标识符：10.1186/s12935-020-01401-w。]
相似文献
1
Correction to: Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy.对《γ-突触核蛋白是口腔癌恶性肿瘤中一种新型的尼古丁反应蛋白》的更正
Cancer Cell Int. 2020 Aug 26;20:410. doi: 10.1186/s12935-020-01478-3. eCollection 2020.
2
Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy.γ-突触核蛋白是口腔癌恶性肿瘤中一种新的尼古丁反应蛋白。
Cancer Cell Int. 2020 Jul 10;20:300. doi: 10.1186/s12935-020-01401-w. eCollection 2020.
3
Correction to: Novel sulphamoylated 2-methoxy estradiol derivatives inhibit breast cancer migration by disrupting microtubule turnover and organization.更正：新型磺酰化2-甲氧基雌二醇衍生物通过破坏微管周转和组织来抑制乳腺癌迁移。
Cancer Cell Int. 2020 Jul 14;20:308. doi: 10.1186/s12935-020-01408-3. eCollection 2020.
4
Correction to: ZEB1‑AS1 initiates a miRNA‑mediated ceRNA network to facilitate gastric cancer progression.对《ZEB1‑AS1启动miRNA介导的ceRNA网络促进胃癌进展》的更正
Cancer Cell Int. 2019 Apr 11;19:95. doi: 10.1186/s12935-019-0797-y. eCollection 2019.
5
Correction to: CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma.对《CBFA2T2与肾细胞癌中的癌症干细胞状态相关》一文的修正
Cancer Cell Int. 2018 May 11;18:73. doi: 10.1186/s12935-018-0564-5. eCollection 2018.
6
Correction to: Virotheranostics, a double-barreled viral gun pointed toward cancer; ready to shoot?对《病毒诊疗学，指向癌症的双管病毒枪；准备开火了吗？》的勘误
Cancer Cell Int. 2020 Oct 30;20:527. doi: 10.1186/s12935-020-01611-2. eCollection 2020.
7
Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy.对《CRISPR-Cas，现代癌症免疫治疗时代的一种强大基因编辑技术》的修正
Cancer Cell Int. 2020 Oct 28;20:521. doi: 10.1186/s12935-020-01609-w. eCollection 2020.
8
Correction to: The mA eraser FTO facilitates proliferation and migration of human cervical cancer cells.对《mA 橡皮擦 FTO 促进人宫颈癌细胞的增殖和迁移》的更正
Cancer Cell Int. 2020 Aug 30;20:423. doi: 10.1186/s12935-020-01473-8. eCollection 2020.
9
Correction to: miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells.对《miR-484通过靶向ZEB1和SMAD2抑制宫颈癌细胞增殖和上皮-间质转化》的更正
Cancer Cell Int. 2020 Jul 17;20:318. doi: 10.1186/s12935-020-01375-9. eCollection 2020.
10
Correction to: Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis.对《通过生物信息学分析鉴定胰腺癌微环境中与预后相关的基因并构建多调控网络》一文的更正
Cancer Cell Int. 2020 Aug 18;20:397. doi: 10.1186/s12935-020-01482-7. eCollection 2020.
本文引用的文献
1
Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy.γ-突触核蛋白是口腔癌恶性肿瘤中一种新的尼古丁反应蛋白。
Cancer Cell Int. 2020 Jul 10;20:300. doi: 10.1186/s12935-020-01401-w. eCollection 2020.
Zotero 插件